Medical Indicators Revenue and Competitors
Estimated Revenue & Valuation
- Medical Indicators's estimated annual revenue is currently $6M per year.
- Medical Indicators's estimated revenue per employee is $251,000
Employee Data
- Medical Indicators has 24 Employees.
- Medical Indicators grew their employee count by -11% last year.
Medical Indicators Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6M | 24 | -11% | N/A | N/A |
#2 | $12.8M | 51 | 46% | N/A | N/A |
#3 | $13.1M | 52 | 8% | N/A | N/A |
#4 | $9.5M | 38 | -3% | N/A | N/A |
#5 | $2.3M | 9 | 29% | N/A | N/A |
#6 | $292.7M | 1166 | 9% | N/A | N/A |
#7 | $311.7M | 1242 | 2% | N/A | N/A |
#8 | $7M | 28 | -10% | N/A | N/A |
#9 | $8M | 32 | 10% | N/A | N/A |
#10 | $12.6M | 50 | 9% | N/A | N/A |
What Is Medical Indicators?
At Medical Indicators, we embrace innovation in our ongoing commitment to providing safer healthcare and a better patient experience. For over 30 years, we've manufactured clinically accurate, FDA-registered disposable thermometers that require no cleaning, calibration, or batteries. Our products, sold under the brand names of Tempa•DOT™, NexTemp®, and TraxIt® are used to take accurate human body temperature readings. We proudly serve healthcare providers and patients, domestically and worldwide. Our products help medical facilities reduce patient-to-patient cross-infection, thereby lowering the overall incidence of Healthcare Acquired Infections (HAIs). Request a sample today and find out why clinicians across the world prefer Medical Indicators' disposable thermometers.
keywords:N/AN/A
Total Funding
24
Number of Employees
$6M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 24 | 14% | N/A |
#2 | N/A | 24 | -17% | N/A |
#3 | $2.2M | 24 | 60% | N/A |
#4 | $4.7M | 25 | -7% | N/A |
#5 | N/A | 25 | -19% | N/A |